Olen Kew

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Reaching the last one per cent: progress and challenges in global polio eradication
    Olen Kew
    Division of Viral Diseases, G 10, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Curr Opin Virol 2:188-98. 2012
  2. ncbi request reprint Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus
    Olen Kew
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention CDC, 1600 Clifton Road, Atlanta, GA 30333, USA
    Science 296:356-9. 2002
  3. pmc Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria
    Cara C Burns
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Virol 87:4907-22. 2013
  4. pmc Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons
    Cara C Burns
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 83:9957-69. 2009
  5. pmc Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient
    Chen Fu Yang
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 79:12623-34. 2005
  6. pmc Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya
    Nino Khetsuriani
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    BMC Infect Dis 9:136. 2009
  7. pmc Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range
    Jaume Jorba
    Polio and Picornavirus Laboratory Branch, G 10, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Virol 82:4429-40. 2008
  8. pmc Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region
    Cara Carthel Burns
    Respiratory and Enteric Viruses Branch, G 10, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, N E, Atlanta, GA 30333, USA
    J Virol 80:3259-72. 2006
  9. pmc Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population
    Steven Wassilak
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 203:898-909. 2011
  10. doi request reprint Poliovirus serotype-specific VP1 sequencing primers
    David R Kilpatrick
    Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Virol Methods 174:128-30. 2011

Collaborators

Detail Information

Publications22

  1. doi request reprint Reaching the last one per cent: progress and challenges in global polio eradication
    Olen Kew
    Division of Viral Diseases, G 10, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Curr Opin Virol 2:188-98. 2012
    ....
  2. ncbi request reprint Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus
    Olen Kew
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention CDC, 1600 Clifton Road, Atlanta, GA 30333, USA
    Science 296:356-9. 2002
    ..The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus...
  3. pmc Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria
    Cara C Burns
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Virol 87:4907-22. 2013
    ..The detection of multiple concurrent cVDPV2 outbreaks in northern Nigeria highlights the risks of cVDPV emergence accompanying tOPV use at low rates of coverage in developing countries...
  4. pmc Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons
    Cara C Burns
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 83:9957-69. 2009
    ....
  5. pmc Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient
    Chen Fu Yang
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 79:12623-34. 2005
    ..The appearance of a chronic VDPV excretor in a tropical, developing country has important implications for the strategy to stop OPV immunization after eradication of wild polioviruses...
  6. pmc Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya
    Nino Khetsuriani
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    BMC Infect Dis 9:136. 2009
    ....
  7. pmc Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range
    Jaume Jorba
    Polio and Picornavirus Laboratory Branch, G 10, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Virol 82:4429-40. 2008
    ....
  8. pmc Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region
    Cara Carthel Burns
    Respiratory and Enteric Viruses Branch, G 10, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, N E, Atlanta, GA 30333, USA
    J Virol 80:3259-72. 2006
    ..Potential applications for the systematic modulation of poliovirus replicative fitness by deoptimization of codon usage are discussed...
  9. pmc Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population
    Steven Wassilak
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 203:898-909. 2011
    ..Strengthened routine immunization programs in countries with suboptimal coverage and balanced use of OPV formulations in SIAs are necessary to minimize risks of VDPV emergence and circulation...
  10. doi request reprint Poliovirus serotype-specific VP1 sequencing primers
    David R Kilpatrick
    Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Virol Methods 174:128-30. 2011
    ....
  11. pmc Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
    Chen Fu Yang
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 77:8366-77. 2003
    ..The potential for cVDPVs to circulate in populations with low immunity to poliovirus has important implications for current and future strategies to eradicate polio worldwide...
  12. ncbi request reprint Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis
    Nino Khetsuriani
    Respiratory and Enteric Viruses Branch, National Center for Infectious Diseases, and National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 188:1845-52. 2003
    ..These results are important for developing "endgame" strategies for the Global Poliomyelitis Eradication Program...
  13. ncbi request reprint Polio today: are we on the verge of global eradication?
    Stephen L Cochi
    Centers for Disease Control and Prevention, Global Immunization Division, 1600 Clifton Rd NE, Mailstop E 05, Atlanta, GA 30333, USA
    JAMA 300:839-41. 2008
  14. ncbi request reprint Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola
    Jan Vinje
    Department of Environmental Sciences and Engineering, School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27599 7431, USA
    J Infect Dis 189:1168-75. 2004
    ..Our findings demonstrate a useful role for environmental surveillance of neurovirulent polioviruses in the overall polio eradication program...
  15. doi request reprint Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia
    Shohreh Shahmahmoodi
    National Polio Laboratory, School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences, Tehran, Iran
    Virus Res 137:168-72. 2008
    ..No secondary AFP cases were found, and none of the seven tested contacts of the patient were found to be infected with poliovirus...
  16. pmc Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar
    Mala Rakoto-Andrianarivelo
    Unite de Virologie Medicale, Institut Pasteur de Madagascar, Antananarivo, Madagascar
    PLoS Pathog 3:e191. 2007
    ..This probably contributed to the emergence of recombinant VDPVs. These findings give further insight into viral ecosystems and the evolutionary processes that shape viral biodiversity...
  17. ncbi request reprint Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management
    Walter Dowdle
    Polio Eradication Program, The Task Force for Child Survival and Development, 750 Commerce Dr, Suite 400, Decatur, GA 30030, USA
    Risk Anal 26:1449-69. 2006
    ..Minimizing the risk of poliovirus transmission from a poliovirus facility to increasingly susceptible communities is a crucial and ongoing effort requiring understanding and actively managing the potential exposure pathways...
  18. ncbi request reprint Vaccine-derived polioviruses: is it time to stop using the word "rare"?
    Walter Dowdle
    J Infect Dis 194:539-41. 2006
  19. ncbi request reprint What role for inactivated poliovirus vaccine in the eradication endgame?
    Olen Kew
    J Infect Dis 193:1341-3. 2006
  20. pmc Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
    Hiroyuki Shimizu
    Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
    J Virol 78:13512-21. 2004
    ..Type 1 cVDPV was last detected in the Philippines in September 2001, and population immunity to polio was raised by extensive OPV campaigns in late 2001 and early 2002...
  21. ncbi request reprint Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
    Festus Adu
    National Poliovirus Laboratory, Department of Virology, College of Medicine, University of Ibadan, UCH, Ibadan, Oyo State, Nigeria
    Virus Res 127:17-25. 2007
    ..Although no related type 2 VDPVs were detected in Nigeria or elsewhere, the VDPV was found in an area where conditions favor VDPV emergence and spread...
  22. ncbi request reprint No evidence for prolonged excretion of polioviruses in persons with residual paralytic poliomyelitis in Ethiopia, Pakistan and Guatemala
    Aamir J Khan
    Department of International Health, Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Room W5041, Baltimore, MD 21205, USA
    Biologicals 34:113-6. 2006
    ..Nevertheless, persistent poliovirus excretion among persons 2 years of age and older with residual paralytic poliomyelitis is uncommon in developing countries...